REFERENCES
1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer in the united states. Arch Dermatol 2010;146:283-7.
2. Brewster DH, Bhatti LA, Inglis JHC, Nairn ER, Doherty VR. Recent trends in incidence of nonmelanoma skin cancers in the east of Scotland, 1992-2003. Brit J Dermatol 2007;156:1295-300.
3. American Cancer Society. Cancer Facts and Figures 2017. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html. [Last accessed on 2 Jan 2019].
4. The Skin Cancer Foundation. Available from: https://www.skincancer.org/skin-cancer-information/skin-cancer-facts. [Last accessed on 9 Jan 2019].
5. Mogensen M, Jemec GBE. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg 2007;33:1158-74.
7. Smith L, MacNeil S. State of the art in non-invasive imaging of cutaneous melanoma. Skin Res Technol 2011;17:257-69.
8. Kong K, Rowlands CJ, Varma S, Perkins W, Leach IH, et al. Diagnosis of tumors during tissue-conserving surgery with integrated autofluorescence and Raman scattering microscopy. Proc Natl Acad Sci U S A 2013;110:15189-94.
9. Heuke S, Vogler N, Meyer T, Akimov D, Kluschke F, et al. Detection and discrimination of non-melanoma skin cancer by multimodal imaging. Healthcare 2013;1:64-83.
10. Alfano RR, Tata D, Cordero J, Tomashefsky P, Longo FW, et al. Laser induced fluorescence spectroscopy from native cancerous and normal tissue. IEEE J Quantum Elect 1984;20:1507-11.
11. Alfano RR, Tang GC, Pradhan A, Lam W, Choy DSJ. Fluorescence spectra from cancerous and normal human breast and lung tissues. IEEE J Quantum Elect 1987;QE-23:1806-11.
12. Liu CH, Alfano RR, Sha WL, Zhu HR, Akins DL, et al. Human breast tissues studied by IR Fourier transform Raman spectroscopy. Lasers Life Sci 1991;4:23-8.
13. Liu CH, Sha Glasman WL, Zhu HR, Akins DL, Deckelbaum LI, et al. Near-IR Fourier transform Raman spectroscopy of normal and atherosclerotic human aorta. Laser in the Life Sciences 1992;43:257-64.
14. Brancaleon L, Durkin AJ, Tu JH, Menaker G, Fallon JD, et al. In vivo fluorescence spectroscopy of nonmelanoma skin cancer. Photochem Photobiol 2001;73:178-83.
15. Panjehpour M, Julius CE, Phan MN, Vo-Dinh T, Overholt S. Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers. Lasers Surg Med 2002;31:367-73.
16. Longo C, Rajadhyaksha M, Ragazzi M, Nehal K, Gardini S, et al. Evaluating ex vivo fluorescence confocal microscopy images of basal cell carcinomas in Mohs excised tissue. Br J Dermatol 2014;171:561-70.
17. Rao BK, Mateus R, Wassef C, Pelecinid G. In vivo confocal microscopy in clinical practice: comparison of bedside diagnostic accuracy of a trained physician and distant diagnosis of an expert reader. J Am Acad Dermatol 2013;69:e295-300.
18. Giambrone D, Alamgir M, Masud A, Bronsnick T, Rao B. The diagnostic accuracy of in vivo confocal microscopy in clinical practice. J Am Acid Dermal 2015;73:317-9.
19. Flores ES, Cordova M, Kose K, Phillips W, Rossi A, et al. Intraoperative imaging during Mohs surgery with reflectance confocal microscopy: initial clinical experience. J Biomed Opt 2015;20:61103.
20. Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol 2008;9:1149-56.
21. Choe CS, Lademann J, Darvin ME. Analysis of human and porcine skin in vivo/ex vivo for penetration of selected oils by confocal Raman microscopy. Skin Pharmacol Physiol 2015;28:318-30.
22. Kourkoumelis N, Balatsoukas I, Moulia V, Elka A, Gaitanis G, et al. Advances in the in vivo Raman spectroscopy of malignant skintumors using portable instrumentation. Int J Mol Sci 2015;16:14554-70.
23. Gniadecka M, Wulf HC, NieIseW OF, Christensen DH, Hercogova J. Distinctive molecular abnormalities in benign and malignant skin lesions: studies by Raman spectroscopy. Photochem Photobiol 1997;66:418-23.
24. Notingher I, Verrier S, Romanska H, Bishop AE, Polak JM, et al. In situ characterization of living cells by Raman spectroscopy. Spectroscopy 2002;16:43-51.
25. Sigurdsson S, Philipsen PA, Hansen LK, Larsen J, Gniadecka M, et al. Detection of skin cancer by classification of Raman spectra. IEEE Trans Biomed Eng 2004;51:1784-93.
26. Nijssen A, Bakker Schut TC, Heule F, Caspers PJ, Hayes DP, et al. Discriminating basal cell carcinoma from its surrounding tissue by Raman spectroscopy. J Invest Dermatol 2002;119:64-9.
27. Nunes LD, Martin AA, Silviera L, Zampieri M. FT-Raman spectroscopy study for skin cancer diagnosis. Spectrosc Int J 2003;17:602.
28. Choi J, Choo J, Chung H, Gweon DG, Park J, et al. Direct observation of spectral differences between normal and basal cell carcinoma (BCC) tissues using confocal Raman microscopy. Biopolymers 2005;77:264-72.
29. Nijssen A, Maquelin K, Santos LF, Caspers PJ, Bakker Schut TC, et al. Discriminating basal cell carcinoma from perilesinal skin using high wave-number Raman spectroscopy. J Biomed Opt 2007;12:034004.
30. Egawa M, Tagam H. Comparison of the depth profiles of water and water-binding substances in the stratum corneum determined in vivo by Raman spectroscopy between the cheek and volar forearm skin: effects of age, seasonal changes and artificial forced hydration. Br J Dermatol 2008;158:251-60.
31. Kumar S, Verma T, Mukherjee R, Ariese F, Somasundaramc K, et al. Raman and infrared microspectroscopy: towards quantitative evaluation for clinical research by ratiometric analysis. Chem Soc Rev 2016;45:1879-900.
32. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011;478:197-203.
33. Waller JM, Maibach HI. Age and skin structure and function, a quantitative approach (I):blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol 2005;11:221-35.
34. Ly E, Piot O, Durlach A, Bernard P, Manfait M. Polarized Raman microspectroscopy canreveal structural changes of peritumoral dermis in basal cell carcinoma. Applied Spectroscopy 2008;62:1088-94.
35. Caspers PJ, Lucasson GW, Carter EA, Bruining HA, Puppels GJ. In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles. J Invest Dermatol 2001;116:434-42.
36. Caspers PJ, Lucassen GW, Wolthuis R, Bruining HA, Puppels GJ. In vitro and in vivo Raman spectroscopy of human skin. Biospectroscopy 1998;4:S31-S9.
37. Zhou Y, Liu CH, Sun Y, Pu Y, Boydston-White S, et al. Human brain cancer studied by resonance Raman spectroscopy. J Biomed Opt 2012;17:116021.
38. Liu CH, Zhou Y, Sun Y, Li JY, Zhou LX, et al. Resonance Raman and Raman spectroscopy for breast cancer detection. Technol Cancer Res Treat 2013;12:371-82.
39. Zhou Y, Liu CH, Li JY, Zhou LX, Chen K, et al. Tumor margin detection using optical biopsy techniques. SPIE Proc 2014;8940:894014.
40. Zhou Y, Liu CH, Zhou LX, Zhu K, Liu YL, et al. Resonant Raman spectra of grades of human brain glioma tumors reveal the content of tryptophan by the 1588 cm-1 mode. Proc SPIE 2015;9318:931810.
41. Liu CH, Boydston-White S, Wang WB, Sordillo LA, Shi LY, et al. Optical pathology study of human abdominal aorta tissues using confocal micro resonance Raman spectroscopy. Proc SPIE 2016;9703:97031S.
42. Liu CH, Boydston-White S, Weisberg A, Wang W, Sordillo LA, et al. Vulnerable atherosclerotic plaque detection by resonance Raman spectroscopy. J Biomed Opt 2016;21:127006.
43. Liu CH, Sriramoju V, Boydston-White S, Wu B, Zhang C, et al. Resonance Raman of BCC and normal skin. Proc SPIE 2017;10060:100601B.
44. Massart DL, Vandeginste BGM, Deming SM, Michotte Y, Kaufman L. Chemometrics: a Textbook. Amsterdam: Elsevier; 1988.
46. Wu B, Nebylitsa SV, Mukherjee S, Jain M. Quantitative diagnosis of bladder cancer by morphometric analysis of HE images. Proc SPIE 2015;9303:930317.
47. Jain M, Robinson BD, Wu B, Khani F, Mukherjee S. Exploring multiphoton microscopy as a novel tool to differentiate chromophobe renal cell carcinoma from oncocytoma in fixed tissue sections. Arch Pathol Lab Med 2017; doi: 10.5858/arpa.2017-0056-OA.
48. Wu B, Mukherjee S, Jain M. A new method using multiphoton imaging and morphometric analysis for differentiating chromophobe renal cell carcinoma and oncocytoma kidney tumors. Proc SPIE 2016;9712:97121O.
49. Mazet V, Carteret C, Brie D, Idier J, Humbert B. Background removal from spectra by designing and minimising a non-quadratic cost function. Chemometr Intell Lab Syst 2005;76:121-33.
50. Jolliffe IT. Principal Component Analysis. New York: Springer; 1986.
52. Wu B, Alrubaiee M, Cai W, Xu M, Gayen SK. Diffuse optical Imaging using decomposition methods. Int J Opt 2012;2012:185435.
53. Golub GH, Reinsch C. Singular value decomposition and least squares solutions. Numer Math 1970;14:403-20.
55. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
56. Platt JC. Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods. Advances in Large Margin Classifiers. Cambridge, MA: MIT Press; 1999. pp. 61-74.
57. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) Curve. Radiology 1982;143:29-36.
58. Leeflang MMG, Moons KGM, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clin Chem 2008;54:729-37.
59. Hata TR, Scholz TA, Ermakov IV, McClane RW, Khachik F, et al. Non-invasive Raman spectroscopic detection of carotenoids in human skin. J Invest Dermatol 2000;115:441-8.
60. Skin Cancer Treatment (PDQ®)-Patient Version. Available from: https://www.cancer.gov/types/skin/patient/skin-treatment-pdq. [Last accessed on 4 Jan 2019].
61. Sandby-Møller J, Poulsen T, Wulf HC. Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol 2003;83:410.
62. Ermakov IV, Sharifzadeh M, Ermakova M, Gellermann W. Resonance Raman detection of carotenoid antioxidants in living human tissue. J Biomed Opt 2005;10:064028.
63. Ermakov IV, Whigham LD, Redelfs AH, Jahns L, Stookey J, et al. Skin carotenoids as biomarker for vegetable and fruit intake: validation of the reflection-spectroscopy based “Veggie Meter”. FASEB J 2016;30:409.
64. Ermakov IV, Ermakova MR, Gellermann W, Lademann J. Noninvasive selective detection of lycopene and beta-carotene in human skin using Raman spectroscopy. J Biomed Opt 2004;9:332-8.
65. Mayne ST, Cartmel B, Scarmo S, Jahns L, Ermakov IV, et al. Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies. Arch Biochem Biophys 2013;539:1-18.
66. Ren H, Biggs JD, Mukamel S. Two-dimensional stimulated ultraviolet resonance Raman spectra of tyrosine and tryptophan; a simulation study. J Raman Spectrosc 2013;44:544-59.
67. Darvin ME, Sterry W, Lademann J, Vergou T. The role of carotenoids in human skin. Molecules 2011;16:10491.
68. Haag SF, Taskoparan B, Darvin ME, Groth N, Lademann J, et al. Determination of the antioxidative capacity of the skin in vivo using resonance Raman and electron paramagnetic resonance spectroscopy. Exp Dermatol 2011;20:483-7.
69. Lademann J, Meinke MC, Sterry W, Darvin ME. Carotenoids in human skin. Exp Dermatol 2011;20:377-82.
70. Wrona M, Korytowski W, Rozanowska M, Sarna T, Truscott TG. Cooperation of antioxidants in protection against photosensitized oxidation. Free Radic Biol Med 2003;35:1319-29.
71. Palozza P, Krinsky NI. beta-Carotene and alpha-tocopherol are synergistic antioxidants. Arch Biochem Biophys 1992;297:184-7.
72. Darvin ME, Sterry W, Lademann J. Resonance Raman spectroscopy as an effective tool for the determination of antioxidative stability of cosmetic formulations. Journal of Biophotonics 2010;3:82-8.
73. Puppels GJ, Schut TCB, Sijtsema NM, Grond M, Maraboeuf F, et al. Development and Application of Raman microspectroscopic and Raman imaging techniques for cell biological studies. Journal of Molecular Structure 1995;347:477-84.
75. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. European Journal of Pharmacology 1999;375:87-100.
76. Fatokun AA, Hunt NH, Ball HJ. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids 2013;45:1319-29.
77. Sordillo PP, Sordillo LA, Helson L. The kynurenine pathway: a primary resistance mechanism in patients with glioblastoma. Anticancer Research 2017;37:2159-71.
78. Shafaat HS, Kim JE. Resonance Raman analysis of the tryptophan cation radical. J Phys Chem Lett 2014;5:3009-14.
79. Shafaat HS, Leigh BS, Tauber MJ, Kim JE. Resonance Raman characterization of a stable tryptophan radical in an azurin mutant. J Phys Chem B 2009;113:382-8.
80. Bleifuss G, Kolberg M, Pötsch S, Hofbauer W, Bittl R, et al. Tryptophan and tyrosine radicals in ribonucleotide reductase: a comparative high-field EPR study at 94 GHz. Biochemistry 2001;40:15362-8.
81. Pandey R, Paidi SK, Kang JW, Spegazzini N. Discerning the differential molecular pathology of proliferative middle ear lesions using Raman spectroscopy. Scientific Reports 2015;5:13305.
82. Bodanese B, Silveira LJ, Albertini R, Zangaro RA, Pacheco MTT. Differentiating normal and basal cell carcinoma human skin tissues in vitro using dispersive Raman spectroscopy: a comparison between principal components analysis and simplified biochemical models. Photomed Laser Surg 2010;28:S119-S27.
83. Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, et al. Intraoperative brain cancer detection with Raman spectroscopy in humans. Sci Transl Med 2015;7:274ra19.
84. Bergholt MS, Zheng W, Ho KY, Teh M, Yeoh KG, et al. Fiberoptic confocal raman spectroscopy for real-time in vivo diagnosis of dysplasia in Barrett’s esophagus. Gastroenterology 2014;146:27-32.
